Home >> Marketplace Directory >> Diabetes panel, 10/16

Diabetes panel, 10/16

image_pdfCreate PDF

 

At the AACC show 2016

October 2016—GlycoMark has partnered with Diazyme Laboratories to offer a diabetes panel to test three different measures of glycemic control on one specimen. The panel includes assays that measure both intermediate- and long-term glucose averages (Diazyme’s Glycated Serum Protein/GSP and Enzymatic HbA1c) along with the GlycoMark test.

The test measures the 1,5-anhydroglucitol molecule in the blood, providing a clinically proven one- to two-week measure of glycemic excursions often related to postprandial sugar spikes. GlycoMark has been a standard part of diabetes testing in Japan for more than 20 years and has been the subject of more than 40 clinical trials around the world. Its partnership with Diazyme marks the first full-scale entry into the U.S. market.

GlycoMark, 888-744-0221

CAP TODAY
X